FindTrial
Sign In

rozpuszczalnik do sporządzania leków parenteralnych

DRUG3 trials

Sponsors

Medical University Of Gdansk, Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher, Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy

Conditions

COVID-19 and other pulmonary parenchyma infections.Sarcopenia is characterized by loss of the muscle mass and function. It develops with age and is associated with a high risk of functional loss in complex activities of daily livingSystemic mastocytosis with a slow course and involvement of the skinand mortality in older adults.deterioration and quality of lifefalls and injurieshospitalizationpatient institutionalization

Phase 2

Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of nandrolone decanoate therapy and therapy with complex physiotherapy and diet in the treatment of sarcopenia
RecruitingCTIS2024-517178-48-00
Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicherand mortality in older adults., deterioration and quality of life, falls and injuries +3
Start: 2023-03-15Target: 168Updated: 2024-10-31
ITPP as an adjunctive treatment for progressive respiratory failure in COVID-19 and other pulmonary parenchymal infections - a randomized, double-blind, non-commercial phase II clinical trial [BREATH2]
CompletedCTIS2024-517878-21-00
Wojskowy Instytut Medyczny Panstwowy Instytut BadawczyCOVID-19 and other pulmonary parenchyma infections.
Start: 2023-11-28End: 2025-06-11Target: 100Updated: 2025-02-10

Phase 3

The use of dupilumab in treatment of indolent systemic mastocytosis with skin involvement
RecruitingCTIS2023-509111-89-00
Medical University Of GdanskSystemic mastocytosis with a slow course and involvement of the skin
Start: 2025-10-15Target: 66Updated: 2025-06-30